Redmile Group’s CVS Health CVS Stock Holding History

Redmile Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-382,400	Closed	-$25.1M	–	83
2018 Q4	$25.1M	Sell	382,400 -11,900	-3%	-$888K	1.01%	32
2018 Q3	$31M	Buy	+394,300	New	+$28.2M	0.95%	39

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Redmile Group's CVS Position: Q1 2019 in Review

Redmile Group sold out of CVS Health (CVS) in Q1 2019, closing a stake of 382,400 shares — an estimated $25.1M sold.

Redmile Group first reported a position in CVS in Q3 2018 and held it in 2 quarters. The position peaked at $31M in Q3 2018. 1,708 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

Redmile Group reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
Redmile Group sold 382,400 CVS Health shares in Q1 2019, an estimated $25.1M.
Redmile Group first reported a position in CVS Health in Q3 2018 and held it in 2 quarters.
Redmile Group's CVS Health position peaked at $31M in Q3 2018.
1,708 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Redmile Group's 13F filing for Q1 2019, filed 15 May 2019.